Overview Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Study to investigate safety, tolerability, and pharmacokinetics of BIBW 2948 BS Phase: Phase 1 Details Lead Sponsor: Boehringer Ingelheim